4//SEC Filing
Cerulean Pharma Inc. 4
Accession 0001209191-17-002068
$DARECIK 0001401914operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:21 PM ET
Size
4.8 KB
Accession
0001209191-17-002068
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
Chief Operating Officer
Transactions
- Award
Common Stock
2016-12-31$0.60/sh+5,733$3,440→ 12,489 total
Footnotes (1)
- [F1]These shares were acquired under the Cerulean Pharma Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Cerulean Pharma Inc.
CIK 0001401914
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401914
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:21 PM ET
- Size
- 4.8 KB